Loading...
Elanco Animal Health Incorporated
ELAN•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.93
$0.25(1.70%)
Elanco Animal Health Incorporated (ELAN) Financial Performance & Statements
Review Elanco Animal Health Incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.50%
↑ 0.50%
Operating Income Growth
-23.01%
↓ 23.006%
Net Income Growth
127.46%
↑ 127.46%
Operating Cash Flow Growth
99.63%
↑ 99.63%
Operating Margin
5.40%
↑ 5.40%
Gross Margin
45.99%
↑ 45.99%
Net Profit Margin
8.43%
↑ 8.43%
ROE
5.99%
↑ 5.99%
ROIC
2.05%
↑ 2.05%
Elanco Animal Health Incorporated (ELAN) Financial Statements
Explore quarterly and annual reports for Elanco Animal Health Incorporated stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1.02B | $1.03B | $1.18B | $1.21B |
Cost of Revenue | $631.00M | $625.00M | $626.00M | $515.00M |
Gross Profit | $389.00M | $405.00M | $558.00M | $690.00M |
Gross Profit Ratio | $0.38 | $0.39 | $0.47 | $0.57 |
R&D Expenses | $81.00M | $87.00M | $89.00M | $87.00M |
SG&A Expenses | $300.00M | $323.00M | $354.00M | $337.00M |
Operating Expenses | $381.00M | $410.00M | $443.00M | $557.00M |
Total Costs & Expenses | $1.01B | $1.03B | $1.07B | $1.07B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $46.00M | $58.00M | $65.00M | $66.00M |
Depreciation & Amortization | $164.00M | $170.00M | $162.00M | $166.00M |
EBITDA | $175.00M | -$5.00M | $195.00M | $299.00M |
EBITDA Ratio | $0.17 | -$0.005 | $0.16 | $0.25 |
Operating Income | $8.00M | -$5.00M | $115.00M | $133.00M |
Operating Income Ratio | $0.008 | -$0.005 | $0.10 | $0.11 |
Other Income/Expenses (Net) | -$59.00M | $564.00M | -$147.00M | -$121.00M |
Income Before Tax | -$51.00M | $559.00M | -$32.00M | $12.00M |
Income Before Tax Ratio | -$0.05 | $0.54 | -$0.03 | $0.010 |
Income Tax Expense | -$43.00M | $195.00M | $18.00M | -$20.00M |
Net Income | -$8.00M | $364.00M | -$50.00M | $32.00M |
Net Income Ratio | -$0.008 | $0.35 | -$0.04 | $0.03 |
EPS | -$0.02 | $0.74 | -$0.10 | $0.06 |
Diluted EPS | -$0.02 | $0.73 | -$0.10 | $0.06 |
Weighted Avg Shares Outstanding | $494.40M | $494.30M | $494.20M | $493.20M |
Weighted Avg Shares Outstanding (Diluted) | $494.40M | $497.70M | $494.20M | $496.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan